Millennium Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-47,600
| Closed | -$3.24M | – | 7764 |
|
|
2022
Q3 | $3.24M | Buy |
+47,600
| New | +$2.63M | ﹤0.01% | 3308 |
|
|
2021
Q3 | – | Sell |
-40,000
| Closed | -$1.4M | – | 7492 |
|
|
2021
Q2 | $1.4M | Buy |
40,000
+30,000
| +300% | +$1.17M | ﹤0.01% | 4336 |
|
|
2021
Q1 | $408K | Buy |
+10,000
| New | +$460K | ﹤0.01% | 4992 |
|
|
2020
Q4 | – | Sell |
-7,500
| Closed | -$414 | – | 5735 |
|
|
2020
Q3 | $414 | Sell |
7,500
-10,000
| -57% | -$636K | ﹤0.01% | 3666 |
|
|
2020
Q2 | $1.1M | Buy |
+17,500
| New | +$1.2M | ﹤0.01% | 2932 |
|
|
2020
Q1 | – | Sell |
-40,000
| Closed | -$3.18M | – | 4728 |
|
|
2019
Q4 | $3.18M | Sell |
40,000
-60,000
| -60% | -$3.56M | ﹤0.01% | 2286 |
|
|
2019
Q3 | $4.85M | Sell |
100,000
-7,100
| -7% | -$370K | 0.01% | 1831 |
|
|
2019
Q2 | $5.63M | Buy |
+107,100
| New | +$6.15M | 0.01% | 1678 |
|
|
2018
Q4 | – | Sell |
-392,300
| Closed | -$14.9M | – | 4333 |
|
|
2018
Q3 | $14.9M | Buy |
392,300
+177,300
| +82% | +$7.85M | 0.02% | 1030 |
|
|
2018
Q2 | $9.72M | Buy |
215,000
+172,000
| +400% | +$7.83M | 0.01% | 1332 |
|
|
2018
Q1 | $2.08M | Buy |
+43,000
| New | +$2.4M | ﹤0.01% | 2287 |
|
|
2016
Q3 | – | Sell |
-50,000
| Closed | -$830K | – | 3718 |
|
|
2016
Q2 | $830K | Buy |
+50,000
| New | +$1.01M | ﹤0.01% | 2250 |
|
Other funds holding GBT
Millennium Management's GBT Position: Q4 2022 in Review
Millennium Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 543,632 shares — an estimated $37M sold.
Millennium Management first reported a position in GBT in Q3 2015 and held it in 24 quarters. The position peaked at $37M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Millennium Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Millennium Management sold 543,632 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $37M.
- Millennium Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 24 quarters.
- Millennium Management's Global Blood Therapeutics, Inc. position peaked at $37M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.